Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Abeona Therapeutics (ABEO) Revenue: 2011-2025

Historic Revenue for Abeona Therapeutics (ABEO) over the last 14 years, with Sep 2025 value amounting to $771,000.

  • Abeona Therapeutics' Revenue rose 786.21% to $771,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 million, marking a year-over-year increase of 94.80%. This contributed to the annual value of $38,000 for FY2024, which is 98.91% down from last year.
  • Per Abeona Therapeutics' latest filing, its Revenue stood at $771,000 for Q3 2025, which was up 92.75% from $400,000 recorded in Q2 2025.
  • Abeona Therapeutics' Revenue's 5-year high stood at $3.5 million during Q2 2023, with a 5-year trough of -$1.5 million in Q2 2021.
  • Moreover, its 3-year median value for Revenue was $312,000 (2025), whereas its average is $582,364.
  • In the last 5 years, Abeona Therapeutics' Revenue skyrocketed by 832.35% in 2023 and then crashed by 141.44% in 2024.
  • Abeona Therapeutics' Revenue (Quarterly) stood at -$48,000 in 2021, then spiked by 241.67% to $68,000 in 2022, then skyrocketed by 832.35% to $634,000 in 2023, then crashed by 109.31% to -$59,000 in 2024, then soared by 786.21% to $771,000 in 2025.
  • Its Revenue stands at $771,000 for Q3 2025, versus $400,000 for Q2 2025 and $312,000 for Q1 2025.